Angiotensin-converting enzyme polymorphism gene and evolution of nephropathy to end-stage renal disease

Nephrology

Volumn 8, Issue 4, 2003, Pages 171-176

  Ortiz, M Angels ^a   De Prado, Anna ^a   Doñate, Teresa ^a   Gallart, Lluis ^a   Claramunt, Helena ^a   Hernández, Marta ^a   Martínez, Joaquin ^a   Martínez, Esther ^a   Pou, Jose M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

DD and II genotype; End stage renal disease; Genetic markers; Nephropathy evolution; Renin angiotensin system

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EVOLUTION; FEMALE; FOLLOW UP; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 0043165069     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1797.2003.00165.x     Document Type: Article

References (24)

1. Harden PN, Geddes C, Rowe PA et al. Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 1995; 345: 1540-2.
2. Yoshioka T, Xu YX, Yoshida H, Shiraga H, Muraki T, Ito K. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schonlein purpura nephritis. Arch. Dis. Child. 1998; 79: 394-9.
3. Amoroso A, Danek G, Vatta S et al. Polymorphism in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schoenlein subjects. Nephrol. Dial. Transplant. 1998; 13: 3184-8.
4. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. N. Engl. J. Med. 1989; 320: 1160-5.
5. Marre M, Jeunemaitre X, Gallois Y et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J. Clin. Invest. 1997; 7: 1585-95.
6. Young RP, Chan JCN, Critchley J, Poon E, Nichos G, Cockram CS. Angiotensin T253 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients. Diabetes Care 1998; 21: 431-7.
7. Chowdhury TA, Dronsfield MJ, Kumar S et al. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 1996; 39: 1108-14.
8. Lau YK. ACE gene polymorphis and disease progression of IgA nephropathy in Asians in Singapore. Nephron 2002; 91: 499-503.
9. Drouet M. Analysis of three genetic markers in IgA nephropathy patients from a single region. Clin. Nephrol. 2002; 57: 253-60.
10. Staessen JA, Wang JG, Ginocchio G et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J. Hypertens. 1997; 15: 1579-92.
11. Ryan AS, Niklas BJ, Berman DM, Ferrell RE. The insertion/deletion polymorphism of the ACE gene is related to insulin sensitivity in overweight women. Diabetes Care 2001; 24: 1545-652.
12. Erdös E, Skidgel RA. The angiotensin I-converting enzyme. Lab. Invest. 1987; 56: 345-8.
13. Ehlers MRW, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1998; 28: 5311-18.
14. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection off the insertion/delection polymorphism of the human angiotensin converting gene (DCP) (dipeptidyl carboxupeptidase. Nucl. Acid Res. 1992; 20: 1433.
15. Rigat B, Hubert Ch, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 1990; 86: 1343-6.
16. Shanmugam V, Sell KW, Saha BK, Mistyping ACE heterozygotes. PCR Meth. Applic. 1993; 3: 120-1.
17. Erdos EG. Angiotensin converting enzyme and the changes in our concepts through the years. Hypertension 1990; 16: 363-70.
18. Yoshida H, Kuriyama S, Atsumi Y et al. Angiotensin 1 converting enzyme polymorphism in non-insulin dependent diabetes mellitus. Kidney Int. 1996; 50: 657-64.
19. Wolf G, Neilson EG. Angiotensin II as a renal growth factor. J. Am. Soc. Nephrol. 1993; 3: 1521-40.
20. Tiret I, Bonnardeaux A, Poirier O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gen polymorphisms on risk of myocardial infarction. Lancet 1994; 334: 910-13.
21. Ruiz J, Blance H, Cohen N et al. Insertion/deletion polymorphism of the angiotensin converting enzyme gene is strongly associated with coronary heart disease in non insulin dependent diabetes mellitus. Proc. Natl Acad. Sci. USA 1994; 91: 3662-5.
22. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infaction. Nature 1992; 359: 641-4.
23. Samani NJ, O'Toole L, Channer K, Wodds KL. A meta-analysis of the association of the deletion allele of the angiotensin converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-12.
24. Fugisawa T, Ikegami H, Kawaguchi Y et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin 1-converting enzyme gene with diabetic nephropathy. Diabetologia 1998; 41: 47-53.